advertisement
Wang TJ 10
Showing records 1 to 10 | Display all abstracts from Wang TJ117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Hsueh CM
PLoS ONE 2024; 19: e0307132
117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Wu LH
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538
117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Tsai CH
PLoS ONE 2024; 19: e0307132
117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Cheng YW; Lin FL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538
117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Huang JC; Lee SH
PLoS ONE 2024; 19: e0307132
117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Hsu KC; Wang MH
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538
117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Wang TJ
PLoS ONE 2024; 19: e0307132
117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Yen JL
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538
117196 One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study
Guo SP
PLoS ONE 2024; 19: e0307132
117976 A novel HDAC8 inhibitor H7E exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress
Wang TJ; Lin TE; Liu YC; Huang WJ; Hsiao G
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 174: 116538
